04/28/2026 12:42
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press releas...
The Huffington Post takes AFP
FRANCE’S VERSION OF THE HUFFINGTON POST WEBSITE WHICH LAUNCHED ON FEBRUARY 23 HAS SUBSCRIBED TO AFP’S TEXT AND PHOTO SERVICE.
FRANCE’S VERSION OF THE HUFFINGTON POST WEBSITE WHICH LAUNCHED ON FEBRUARY 23 HAS SUBSCRIBED TO AFP’S TEXT AND PHOTO SERVICE.
Anglais
AFP and Jiji Press Announce Launch of “Fastlook” Japanese News Platform
Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.
Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.
Anglais
